Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05166811 · ClinicalTrials.gov registry record · Phase 2
Timely Intravenous Magnesium for Asthma in Children
A Phase 2 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 2
- Development phase
- 52
- Enrollment target
NCT05166811 is a Phase 2 study that has completed, run by University of Utah. The registered enrollment target is 52 participants.
The verdict
NCT05166811, a Phase 2 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 52 participants
- Enrollment target
Study Summary
Many children currently being hospitalized with severe asthma could potentially avoid hospitalization and be sent home if their treatment in the emergency department was more effective. The investigators will conduct a pilot trial that will lead to a larger study to conclusively answer whether a simple and inexpensive medicine, intravenous magnesium sulfate, can be used in the emergency department to prevent hospitalization for these children.
Interventions
- DRUG 0.9% saline
- DRUG Magnesium Sulfate, Heptahydrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2022-09-12 |
| Est. Completion | 2023-07-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05166811
The ClinicalTrials.gov registry entry for NCT05166811 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 0.9% saline is the first listed.
NCT05166811 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05166811 about?
NCT05166811 is a clinical study titled "Timely Intravenous Magnesium for Asthma in Children". Many children currently being hospitalized with severe asthma could potentially avoid hospitalization and be sent home if their treatment in the emergency department was more effective. The investigators will conduct a pilot trial that will lead to a larger study to conclusively answer whether a sim...
What is the current status of trial NCT05166811?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 52 participants. The study started on 2022-09-12. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT05166811?
The interventions under investigation include: 0.9% saline (DRUG), Magnesium Sulfate, Heptahydrate (DRUG).
Who is sponsoring clinical trial NCT05166811?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.